NO953003L - Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater - Google Patents

Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater

Info

Publication number
NO953003L
NO953003L NO953003A NO953003A NO953003L NO 953003 L NO953003 L NO 953003L NO 953003 A NO953003 A NO 953003A NO 953003 A NO953003 A NO 953003A NO 953003 L NO953003 L NO 953003L
Authority
NO
Norway
Prior art keywords
ifenprodil
diastereoisomers
preparation
medical preparations
preparations
Prior art date
Application number
NO953003A
Other languages
English (en)
Other versions
NO953003D0 (no
Inventor
Jesus Benavides
Badia Ferzaz
Pascal George
Bernard Scatton
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO953003D0 publication Critical patent/NO953003D0/no
Publication of NO953003L publication Critical patent/NO953003L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisiner som er nyttige for behandling av perifere nevropatier og kroniske nevrodegenerative sykdommer i sentralnervesystemet.
NO953003A 1994-07-29 1995-07-28 Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater NO953003L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409410A FR2722989B1 (fr) 1994-07-29 1994-07-29 Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales

Publications (2)

Publication Number Publication Date
NO953003D0 NO953003D0 (no) 1995-07-28
NO953003L true NO953003L (no) 1996-01-30

Family

ID=9465882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953003A NO953003L (no) 1994-07-29 1995-07-28 Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater

Country Status (8)

Country Link
US (1) US5543421A (no)
EP (1) EP0698391A1 (no)
JP (1) JPH0840902A (no)
KR (1) KR960003718A (no)
CA (1) CA2154906A1 (no)
FI (1) FI953622A7 (no)
FR (1) FR2722989B1 (no)
NO (1) NO953003L (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742051B1 (fr) * 1995-12-06 1998-02-06 Synthelabo Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
UA115968C2 (uk) * 2011-03-01 2018-01-25 Фарнекст Нові композиції для лікування неврологічних захворювань
SMT202000576T1 (it) 2014-10-03 2020-11-10 Lachesis Biosciences Ltd Composizioni intranasali per il trattamento di malattie e disturbi neurologici e neurodegenerativi
JPWO2021241504A1 (no) * 2020-05-25 2021-12-02

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (no) * 1966-09-27 1968-01-22
US5089506A (en) * 1990-04-30 1992-02-18 G. D. Searle & Co. Ethanobicyclic amine derivatives for cns disorders
EP0557290A1 (en) * 1990-08-23 1993-09-01 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.

Also Published As

Publication number Publication date
US5543421A (en) 1996-08-06
FI953622L (fi) 1996-01-30
NO953003D0 (no) 1995-07-28
CA2154906A1 (en) 1996-01-30
FI953622A7 (fi) 1996-01-30
JPH0840902A (ja) 1996-02-13
KR960003718A (ko) 1996-02-23
FR2722989B1 (fr) 1997-05-30
FI953622A0 (fi) 1995-07-28
EP0698391A1 (fr) 1996-02-28
FR2722989A1 (fr) 1996-02-02

Similar Documents

Publication Publication Date Title
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
CS553490A3 (en) Transdermal therapeutic system
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE59204364D1 (de) Zahnärztlicher Patientenstuhl.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
DK0781560T3 (da) Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
TR199901385T2 (xx) Piperidin t�revleri.
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
FI950649L (fi) Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet
NO904041D0 (no) Terapeutisk aktiv eksopolymer og fremgangsmaate for dens fremstilling.